Metraipolis › archive › dc_09e77f8d413f

Carvedilol decreases hepatic vascular resistance by reducing fibrogenesis and reversing endothelial dysfunction in cirrhotic rats — Europe PMC PMID:41659769

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41659769
DOI
10.1016/j.jhepr.2025.101681
License (as archived)
solo-consultazione
Archived
2026-11-08T09:48:34.393Z
SHA-256 of the archived text
032c55ccc9d4d421f42e507f4078c4671df8f5d840dee25222e87699f5745670
Stable URL of this page
https://metraipolis.com/documento/dc_09e77f8d413f

How to cite

Carvedilol decreases hepatic vascular resistance by reducing fibrogenesis and reversing endothelial dysfunction in cirrhotic rats — Europe PMC PMID:41659769 — Europe PMC (en), https://europepmc.org/article/MED/41659769 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09e77f8d413f (Metraipolis archive dc_09e77f8d413f, sha256 032c55ccc9d4d421f42e507f4078c4671df8f5d840dee25222e87699f5745670)
BibTeX
@misc{dc09e77f8d413f,
  title = {Carvedilol decreases hepatic vascular resistance by reducing fibrogenesis and reversing endothelial dysfunction in cirrhotic rats — Europe PMC PMID:41659769},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41659769},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09e77f8d413f; sha256 032c55ccc9d4d421f42e507f4078c4671df8f5d840dee25222e87699f5745670},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41659769. Agents can read the archived copy with the MCP tool read_document.